SYNTHETIC CANNABINOIDS

Synthetic cannabinoids (SCs) are the largest and most diverse group of new psychoactive substances currently monitored in Europe, with 209 new SCs being reported between 2008 and 2020. 

 

Regulatory bodies and drug testing laboratories have previously been challenged when tasked with identifying new SC substances. The EUFORiaR project will address the urgent need to supply SC reference materials to rapidly identify, quantify and risk assess these substances. 

 

View our range of Synthetic Cannabinoid standards.